Euthymics Reports Top-Line Results From TRIADE Trial Of Amitifadine For Major Depressive Disorder

Euthymics Bioscience, Inc. today announced top-line results from TRIADE (Triple Reuptake Inhibitor Anti-Depressant Effects).

 

FINAL_Euthymics_TRIADE_Results_052913